Your browser doesn't support javascript.
loading
High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate.
Brinck, Jonas W; Thomas, Aurélien; Brulhart-Meynet, Marie-Claude; Lauer, Estelle; Frej, Cecilia; Dahlbäck, Björn; Stenvinkel, Peter; James, Richard W; Frias, Miguel A.
Afiliação
  • Brinck JW; Division of Endocrinology, Diabetology, Hypertension and Nutrition, Department of Internal Medicine Specialities, Medical Faculty, Geneva University, Geneva, Switzerland.
  • Thomas A; Metabolism Unit, Department of Endocrinology, Metabolism and Diabetes, Molecular Nutrition Unit, Center for Innovative Medicine, Huddinge, Sweden.
  • Brulhart-Meynet MC; KI/AZ Integrated CardioMetabolic Center, Department of Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Sweden.
  • Lauer E; Unit of Toxicology, University Centre of Legal Medicine, Lausanne, Geneva, Switzerland.
  • Frej C; Division of Endocrinology, Diabetology, Hypertension and Nutrition, Department of Internal Medicine Specialities, Medical Faculty, Geneva University, Geneva, Switzerland.
  • Dahlbäck B; Unit of Toxicology, University Centre of Legal Medicine, Lausanne, Geneva, Switzerland.
  • Stenvinkel P; Department of Translational Medicine, Division of Clinical Chemistry, Skåne University Hospital, Lund University, Malmö, Sweden.
  • James RW; Department of Translational Medicine, Division of Clinical Chemistry, Skåne University Hospital, Lund University, Malmö, Sweden.
  • Frias MA; Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska University Hospital, Stockholm, Sweden.
Eur J Clin Invest ; 48(2)2018 Feb.
Article em En | MEDLINE | ID: mdl-29178180
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esfingosina / Lisofosfolipídeos / Estresse Oxidativo / Falência Renal Crônica / Lipoproteínas HDL Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Clin Invest Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esfingosina / Lisofosfolipídeos / Estresse Oxidativo / Falência Renal Crônica / Lipoproteínas HDL Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Clin Invest Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suíça